Palladium-103 plaque radiotherapy for choroidal melanoma: an 11-year study
Authors:
- Paul T FingerPFPaul T Finger
- Anthony BersonABAnthony Berson
- Tracy NgTNTracy Ng
- Andrzej SzechterASAndrzej Szechter
- 1 December 2002
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 54 (5) , 1438-1445
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma I. visual acuity after 3 years COMS report no. 16Ophthalmology, 2001
- Tumour location affects the incidence of cataract and retinopathy after ophthalmic plaque radiation therapyBritish Journal of Ophthalmology, 2000
- EnucleationSurvey of Ophthalmology, 2000
- Impact of Delayed Treatment in Growing Posterior Uveal MelanomasArchives of Ophthalmology (1950), 1993
- Treatment of choroidal melanoma with I-125 plaqueInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993
- Improved iodine-125 plaque design in the treatment of choroidal malignant melanoma.British Journal of Ophthalmology, 1992
- Palladium 103 Ophthalmic Plaque RadiotherapyArchives of Ophthalmology (1950), 1991
- 106Ru/106Rh plaque radiotherapy for malignant melanomas of the choroidDocumenta Ophthalmologica, 1988
- Irradiation of Choroidal Melanoma With Iodine 125 Ophthalmic PlaqueArchives of Ophthalmology (1950), 1980
- The treatment of ophthalmic tumours with low-energy sourcesBritish Journal of Radiology, 1976